Avantor, Inc. $AVTR Shares Purchased by Amundi

Key Points

• Amundi increased its Avantor stake by 357.3% in the first quarter, owning 531,575 shares valued at approximately $4.17 million. Institutional investors collectively hold 95.08% of the company.
• Analyst sentiment remains cautious, with a consensus “Hold” rating from 18 analysts and an average price target of $12.00, despite several firms raising their targets and ratings.
• Avantor surpassed quarterly expectations, reporting $0.21 EPS versus $0.19 expected and $1.69 billion in revenue. The company reaffirmed fiscal 2026 EPS guidance of $0.80–$0.83.

Amundi increased its holdings in Avantor, Inc. (NYSE:AVTR - Free Report) by 357.3% in the first quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 531,575 shares of the company's stock after purchasing an additional 415,342 shares during the quarter. Amundi owned 0.08% of Avantor worth $4,168,000 at the end of the most recent reporting period.

A number of other hedge funds also recently bought and sold shares of the business. Private Trust Co. NA grew its position in shares of Avantor by 46.2% in the fourth quarter. Private Trust Co. NA now owns 2,769 shares of the company's stock valued at $32,000 after purchasing an additional 875 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its holdings in Avantor by 28.1% in the 3rd quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 4,123 shares of the company's stock worth $49,000 after buying an additional 905 shares during the last quarter. Osaic Holdings Inc. boosted its holdings in Avantor by 60.9% in the 2nd quarter. Osaic Holdings Inc. now owns 2,810 shares of the company's stock worth $38,000 after buying an additional 1,064 shares during the last quarter. UMB Bank n.a. increased its stake in Avantor by 17.6% during the 4th quarter. UMB Bank n.a. now owns 7,371 shares of the company's stock worth $84,000 after buying an additional 1,101 shares in the last quarter. Finally, EverSource Wealth Advisors LLC raised its holdings in shares of Avantor by 119.1% during the second quarter. EverSource Wealth Advisors LLC now owns 2,187 shares of the company's stock valued at $29,000 after acquiring an additional 1,189 shares during the last quarter. Hedge funds and other institutional investors own 95.08% of the company's stock.

Wall Street Analyst Weigh In

Several research firms have recently weighed in on AVTR. Morgan Stanley raised their target price on Avantor from $10.00 to $14.00 and gave the company an "equal weight" rating in a research report on Thursday, July 30th. Wolfe Research raised Avantor from a "strong sell" rating to a "hold" rating in a research note on Thursday, July 30th. Wall Street Zen upgraded Avantor from a "hold" rating to a "buy" rating in a report on Saturday, June 27th. Zacks Research raised shares of Avantor from a "strong sell" rating to a "hold" rating in a research note on Thursday, April 30th. Finally, Royal Bank Of Canada upped their target price on shares of Avantor from $9.00 to $14.00 and gave the stock a "sector perform" rating in a report on Thursday, July 30th. Two investment analysts have rated the stock with a Buy rating, fifteen have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of "Hold" and a consensus target price of $12.00.

Avantor Stock Performance

Shares of Avantor stock opened at $13.21 on Friday. Avantor, Inc. has a one year low of $7.26 and a one year high of $15.93. The company has a market cap of $8.93 billion, a price-to-earnings ratio of -15.72, a PEG ratio of 10.06 and a beta of 0.89. The company has a debt-to-equity ratio of 0.65, a quick ratio of 1.18 and a current ratio of 1.78. The business's 50 day moving average price is $10.66 and its 200 day moving average price is $9.47.

Avantor (NYSE:AVTR - Get Free Report) last issued its earnings results on Wednesday, July 29th. The company reported $0.21 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.19 by $0.02. Avantor had a positive return on equity of 9.92% and a negative net margin of 8.81%.The company had revenue of $1.69 billion during the quarter, compared to analysts' expectations of $1.61 billion. During the same period in the prior year, the business earned $0.24 EPS. The firm's quarterly revenue was up .5% on a year-over-year basis. Avantor has set its FY 2026 guidance at 0.800-0.830 EPS. On average, research analysts predict that Avantor, Inc. will post 0.81 EPS for the current year.

Avantor Company Profile

Avantor, Inc NYSE: AVTR is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.

Avantor's offerings are organized across two primary segments.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source